Get started
Author

Jim Griffith

ORCID: 0009-0006-4504-7760
Observed ORCID: 0009-0006-4504-7760
OpenAlex ID: A5110051750
The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation
1994 · David Milan, Jim Griffith, et al. · Cell · 105
The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al. · Cancer Research · 68
Data from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al. · 1
Figure S1 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S7 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S5 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Supplementary Table 3 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S6 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S4 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S3 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S2 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S9 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S8 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2026 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S8 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S5 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S2 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S3 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S4 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S7 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S1 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Supplementary Table 1 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S9 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Supplementary Table 3 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Supplementary Table 1 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Figure S6 from The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors
2024 · Louise Cadzow, Jehrod Brenneman, et al.
Works count: 25
Citation count: 174
H-index: 2
I10-index: 2
Year
Topic
Type